Altogether, our results demonstrate a new level of control of HNF1α by TGFβ that can represent the first event in triggering EMT process in hepatocyte and disclose a potential limitation to the use of an exogenous molecule as therapeutic MET inducer and tumor suppressor tool. Here, TGFB1 is linked to neoplasm.